Amalgamated Financial’s Precision BioSciences DTIL Stock Holding History

Amalgamated Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$25K	Buy	+275	New	+$37.4K	﹤0.01%	2676

Other funds holding DTIL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Amalgamated Financial's DTIL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Precision BioSciences (DTIL) in Q1 2022: 275 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #2676 among its holdings.

152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

Amalgamated Financial held 275 shares of Precision BioSciences worth $25K as of Q1 2022.
Precision BioSciences was a new Amalgamated Financial position in Q1 2022.
Precision BioSciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2676 holding.
152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.